ZENTALIS PHARMACEUTICALS, INC. (ZNTL)
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Duos Technologies Reports Second Quarter 2026 Results
Riskified分析發現:旅遊詐騙分子適應速度已超過傳統訊號辨識能力,5月航班詐騙風險飆升32%